RWS
SUPN icon

Retirement Wealth Solutions’s Supernus Pharmaceuticals SUPN Stock Holding History

Retirement Wealth Solutions’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.76K Sell
41
-4
-9% -$182 ﹤0.01% 619
2026
Q2 		$2.09K Sell
45
-10
-18% -$480 ﹤0.01% 518
2026
Q1 		$2.84K Buy
55
+9
+20% +$458 ﹤0.01% 427
2025
Q4 		$2.29K Buy
46
+18
+64% +$875 ﹤0.01% 434
2025
Q3 		$1.34K Buy
+28
New +$1.13K ﹤0.01% 509

Other funds holding SUPN

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Retirement Wealth Solutions's SUPN Position: Q3 2026 in Review

Retirement Wealth Solutions reduced its Supernus Pharmaceuticals (SUPN) stake by 8.9% in Q3 2026, selling an estimated $182 and leaving 41 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Retirement Wealth Solutions first reported a position in SUPN in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.84K in Q1 2026. 8 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.

  • Retirement Wealth Solutions held 41 shares of Supernus Pharmaceuticals worth $1.76K as of Q3 2026.
  • Retirement Wealth Solutions sold 4 Supernus Pharmaceuticals shares in Q3 2026, an estimated $182.
  • Supernus Pharmaceuticals made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q3 2026, its #619 holding.
  • Retirement Wealth Solutions first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Retirement Wealth Solutions's Supernus Pharmaceuticals position peaked at $2.84K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.

Based on Retirement Wealth Solutions's 13F filing for Q3 2026, filed 7 Oct 2026.